Company intelligence / Profile preview

Barr Pharmaceuticals

Woodcliff Lake, New Jersey, USAen.wikipedia.org ↗
Ownership
Private
Employees
~236
Development stage
Commercial
01

Overview

At the time of its acquisition by Teva in December 2008 for $7.5–$8.9 billion, Barr was the fourth largest generic drug company in the US with a strong presence in women’s health and a broad portfolio of both generic and proprietary pharmaceuticals. The company had recently expanded globally through acquisitions such as PLIVA. Its integration into Teva created one of the world’s largest generics businesses.

Therapeutic areas
OncologyInfectious DiseasesEndocrinologyImmunologyPsychiatryDermatologyWomen's Health
Modalities
Small molecules (generics and proprietary drugs)Some biologics via PLIVA subsidiary
Industry
Biotech
02

Drug pipeline

4 assets

tamoxifen

Commercial
Indications
Breast cancer

3 more assets in the full pipeline.

Request access →
03

Partnerships

DuPont alliance for new drug development/marketing pre-acquisitionOther licensing/joint ventures with global pharma companies

Beyond the preview

Go deeper on Barr Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Barr Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call